Advancing Laparoscopic Surgery Through Innovation

TransEnterix is a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery for patients, surgeons, and health care facilities.

Patient-Side Robotic Surgery

TransEnterix is developing the SurgiBot System to enhance laparoscopic surgery through robotic assistance, while allowing surgeon to remain patient-side, in the sterile field.

Enabling Flexible Laparoscopy

TransEnterix developed flexible, catheter-based instruments to transmit the dexterity of the surgeon's motions through articulating channels.

Advancing Laparoscopic Surgery Through Innovation

TransEnterix is currently developing a patient-side robotic system called the SurgiBot™ System. The system is designed to be controlled directly by the surgeon, with enhanced vision and robotic motion. SurgiBot System design incorporates deployment of flexible instruments and a high-definition 3D articulating scope through a single incision.

The SurgiBot System is currently in development and has not yet been cleared by the FDA for sale in the United States or by other regulatory authorities for sale outside the United States.

Learn More

News

April 22, 2015
TransEnterix Schedules First Quarter 2015 Financial and Operating Results Conference Call for May 6, 2015

Read More

April 16, 2015
TransEnterix Announces Completion of GLP Studies

Read More

April 01, 2015
MedDevice Online: Developing A Surgical Robotics System That Doctors Really Want — And Hospitals Can Afford

Read More

May 05, 2015
BioTuesdays: TransEnterix readying FDA filing of SurgiBot in midyear

Read More

Investors

Resources

Fourth Quarter and Fiscal Year 2014 Financial and Operating Results Conference Call:

Listen to Webcast